4/A//SEC Filing
Bisker-Leib Vered 4/A
Accession 0000899243-22-007413
CIK 0001738021other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:30 PM ET
Size
5.6 KB
Accession
0000899243-22-007413
Insider Transaction Report
Form 4/AAmended
Bisker-Leib Vered
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-18+500,000→ 500,000 totalExercise: $2.40Exp: 2032-02-17→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The options vest over 48 substantially equal monthly installments starting 03/17/2022.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001814093
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:30 PM ET
- Size
- 5.6 KB